AGIO — Agios Pharmaceuticals Inc.

Ownership history in BB BIOTECH AG · 20 quarters on record

This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Agios Pharmaceuticals Inc. (AGIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

6.77% (2014 Q4)

Avg. % of fund

4.67%

First filed

2014 Q2

Last filed

2019 Q1

Quarters held

20

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2019 Q1	ADDED	2,978,134	+100,000	+3.5%	5.05%	$200.8M	$67.44
2018 Q4	ADDED	2,878,134	+680,203	+30.9%	4.25%	$132.7M	$46.11
2018 Q3	UNCHANGED	2,197,931	—	0%	4.49%	$169.5M	$77.12
2018 Q2	REDUCED	2,197,931	-337,322	-13.3%	5.35%	$185.1M	$84.23

% of Fund (quarterly) AGIO price (monthly, adj. close)

Other funds also holding AGIO

As of 2025 Q4 — sorted by position size

MPM BioImpact LLC 3Y 4.06% Exome Asset Management LLC 1.78% Rock Springs Capital Management LP 3Y 7Y 1.12% TCG Crossover Management, LLC 3Y 1.06% HighVista Strategies LLC 3Y 7Y 1.04% ARMISTICE CAPITAL, LLC 3Y 7Y 0.98% ARMISTICE CAPITAL, LLC 3Y 7Y 0.97% Frazier Life Sciences Management, L.P. 3Y 0.94% Tetragon Partners GP Ltd 3Y 7Y 0.93% Palo Alto Investors LP 3Y 7Y 0.81%

← Back to BB BIOTECH AG Holdings